Study of the Efficacy and Safety of MEDI4893

NCT02296320 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

213

Enrollment

INDUSTRY

Sponsor class

Conditions

Staphylococcus Aureus Pneumonia

Interventions

DRUG: MEDI4893
OTHER: Placebo

Sponsor

MedImmune LLC

Collaborators

[object Object]
[object Object]
[object Object]